Co-Diagnostics, Inc. ("Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial ...
Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute ...
Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results